NATICK, Mass., Jan. 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has been awarded a contract by the U.S. Department of Veterans Affairs (VA) for a full line of the Company's pacemakers and defibrillators. The one-year contract took effect last month and has annual renewal options for up to four years. It includes Boston Scientific's newest technologies in both product categories: the ALTRUA(TM) family of pacemakers and the TELIGEN(TM) implantable cardioverter defibrillator.
The contract provides Boston Scientific the opportunity to supply life-saving and life-improving therapies to VA patients at risk of sudden cardiac death and bradycardia arrhythmias. Overall patient enrollment at VA Medical Centers has increased from 4.8 million in 2000 to 8.0 million in 2008 and is projected to continue growing.
"We are committed to working with physicians at VA Medical Centers across the country to provide our implantable therapy options for their cardiac rhythm management patients," said Fred Colen, President, Boston Scientific Cardiac Rhythm Management. "During the past two years, we have made substantial improvements to our quality and reliability systems, which will enable us to better serve VA physicians and their patients."
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.
Reference herein to any specific commercial products, process, or service does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government. The views and opinions of authors expre
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved